France Raises Alarm over ‘Very Disturbing’ Spike in Sudden Deaths of Babies Since Introduction of New RSV Vaccine

17

“Independent researchers discovered a “very alarming” and “disturbing” spike in newborn deaths in France coinciding with the rollout of vaccines for infants. This increase, the researchers said, coincides with the introduction of Beyfortus RSV vaccine in French hospitals, which began on Sept. 15, 2023. The drug is offered as a “one-time shot for infants born just before or during the RSV season and for those less than 8 months old before the season starts,” and for some high-risk 8- to 19-month-old infants.”

French researchers and other medical experts warned that no long-term studies have been conducted involving Beyfortus and newborns and that the administration of monoclonal antibodies on this population is unprecedented.

We need long term studies. We need data. Our babies are not guinea pigs.

ADVERTISEMENT

French Researchers Identify ‘Improbably High Rate of Deaths’ in Newborns Who Received New RSV Shot

The Centers for Disease Control and Prevention (CDC) recommended Beyfortus in August 2023 and included it in the C.D.C.’s Vaccines For Children program,

The New York Times has been pushing it.

I do not trust these new vaccines, increasingly they are using the new technology and you don’t know what you’re getting.

France Raises Alarm over ‘Very Disturbing’ Spike in Sudden Deaths of Babies

By: Hunter Fielding, News Addict, January 5, 2024:

ADVERTISEMENT

French researchers have raised the alarm over the “abnormal” and “improbably high rate” of sudden deaths among newborn babies in France.

Independent researchers discovered a “very alarming” and “disturbing” spike in newborn deaths in France coinciding with the rollout of vaccines for infants.

French researchers identified possible safety signals in babies coinciding with the rollout of Beyfortus, a recently approved monoclonal antibody treatment for respiratory syncytial virus (RSV) in newborns.

The discovery comes as public health authorities ramp up warnings about the spread of respiratory viruses and step up their promotion of the drug.

In interviews with The Defender, the researchers — French independent scientist and author Hélène Banoun, Ph.D., and French statistician Christine Mackoi — explained that data from France’s National Institute of Statistics and Economic Studies (INSEE) indicates an improbably high rate of deaths of babies between 2 and 6 days old in France during September and October 2023.

INSEE is the authority that compiles official birth and death data in France.

This increase, the researchers said, coincides with the introduction of Beyfortus in French hospitals, which began on Sept. 15, 2023.

ADVERTISEMENT

In an interview with cardiologist Peter McCullough, M.D., MPH, Banoun said that over 200,000 newborn babies in France have been injected with Beyfortus since that date.

The Centers for Disease Control and Prevention (CDC) recommended Beyfortus in August 2023, while the European Medicines Agency (EMA) authorized the drug in September 2022.

Beyfortus was developed jointly by AstraZeneca and Sanofi.

Keep reading….

The Truth Must be Told

Your contribution supports independent journalism

Please take a moment to consider this. Now, more than ever, people are reading Geller Report for news they won't get anywhere else. But advertising revenues have all but disappeared. Google Adsense is the online advertising monopoly and they have banned us. Social media giants like Facebook and Twitter have blocked and shadow-banned our accounts. But we won't put up a paywall. Because never has the free world needed independent journalism more.

Everyone who reads our reporting knows the Geller Report covers the news the media won't. We cannot do our ground-breaking report without your support. We must continue to report on the global jihad and the left's war on freedom. Our readers’ contributions make that possible.

Geller Report's independent, investigative journalism takes a lot of time, money and hard work to produce. But we do it because we believe our work is critical in the fight for freedom and because it is your fight, too.

Please contribute here.

or

Make a monthly commitment to support The Geller Report – choose the option that suits you best.

ADVERTISEMENT
Quick note: We cannot do this without your support. Fact. Our work is made possible by you and only you. We receive no grants, government handouts, or major funding. Tech giants are shutting us down. You know this. Twitter, LinkedIn, Google Adsense, Pinterest permanently banned us. Facebook, Google search et al have shadow-banned, suspended and deleted us from your news feeds. They are disappearing us. But we are here.

Subscribe to Geller Report newsletter here— it’s free and it’s essential NOW when informed decision making and opinion is essential to America's survival. Share our posts on your social channels and with your email contacts. Fight the great fight.

Follow Pamela Geller on Gettr. I am there. click here.

Follow Pamela Geller on
Trump's social media platform, Truth Social. It's open and free.

Remember, YOU make the work possible. If you can, please contribute to Geller Report.

Join The Conversation. Leave a Comment.

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spammy or unhelpful, click the ... symbol to the right of the comment to let us know. Thank you for partnering with us to maintain fruitful conversation.

 

ADVERTISEMENT
Thanks for sharing!